What Does 23andMe Do?

Total employees686
HeadquartersSouth San Francisco
Founded

23andMe is a leading consumer genetics and research company. Founded in 2006, its mission is to help people access, understand, and benefit from the human genome. 23andMe offers direct-to-consumer genetic testing services that provide customers with information about their ancestry, genetic health risks, carrier status for inherited conditions, and inherited traits. Customers provide a saliva sample, which is analyzed in CLIA-certified and CAP-accredited labs. Beyond individual insights, 23andMe also conducts research, with consent from its customers, to make new genetic discoveries. The company aims to empower individuals with genetic information and drive scientific advancements through its large-scale research platform and therapeutics development.

Where Is 23andMe's Headquarters?

23andMe office23andMe office23andMe office23andMe office
*Images sourced via web search. Rights belong to original owners

HQ Function

Serves as the central hub for research and development, corporate operations, data science, engineering, product development, and laboratory operations.

Notable Features:

State-of-the-art laboratory facilities co-located with corporate offices, fostering seamless collaboration between research, development, and business teams. Situated in a campus environment common for biotech companies in the area.

Work Culture:

A science-driven, innovative, and mission-oriented environment. Employees are passionate about genetics, health, and empowering individuals with personal information. Emphasis on collaboration, data-driven decisions, and contributing to scientific discovery.

HQ Significance:

Strategically located in a major U.S. biotech cluster, allowing access to top talent, research institutions, and industry partners. It centralizes key company functions crucial for its direct-to-consumer genetics and therapeutics research businesses.

Values Reflected in HQ: The HQ's integration of office and lab space reflects 23andMe's commitment to scientific rigor, innovation, and the translation of genetic insights into practical applications for consumers and therapeutic development.

Location:

While 23andMe is headquartered in the US and its primary market has historically been North America, its services are available in many countries worldwide. This includes shipping DNA collection kits internationally to supported countries and providing genetic reports accessible online. Their research platform also benefits from a global customer base, enabling diverse genetic studies. Laboratory processing is centralized in CLIA-certified labs, typically located in the US. Regulatory approvals and product offerings can vary by country.

Street Address:

349 Oyster Point Blvd

City:

South San Francisco

State/Province:

CA

Country:

USA

Where Else Does 23andMe Operate Around the World?

Sunnyvale, CA, USA

Address: Specific address not publicly listed for this small supporting office.

Provides additional flexible office space within Silicon Valley, potentially for specialized teams or functions that benefit from a location distinct from the main biotech-focused HQ.

Buying Intent Signals for 23andMe

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading 23andMe? Meet the Executive Team

As of April 2025, 23andMe' leadership includes:

Anne Wojcicki - Co-Founder and Chief Executive Officer
Joseph R. Arron, M.D., Ph.D. - Chief Scientific Officer
Elias Duncan - Acting Chief Financial Officer
Kathy Hibbs - Chief Administrative Officer
William G. (Bill) Krenz - Chief Digital Officer
Jennifer Low, M.D., Ph.D. - Head of Therapeutics
John Smolen - Chief Commercial Officer

Who's Investing in 23andMe?

23andMe has been backed by several prominent investors over the years, including:

GV (Google Ventures)
Sequoia Capital
Fidelity Management & Research Company
New Enterprise Associates (NEA)
MPM Capital
GlaxoSmithKline (GSK)
Virgin Group (via SPAC merger VG Acquisition Corp.)

What Leadership Changes Has 23andMe Seen Recently?

Hire4
Exits1

23andMe has actively reshaped its executive leadership over the past year (June 2023 - June 2024), appointing a new Chief Scientific Officer, an Acting Chief Financial Officer, a Chief Commercial Officer, and a Chief Digital Officer to steer its next phase of growth and therapeutic development. This period also saw a transition from an interim CFO.

Departures

Joseph Selsavage, Joseph Selsavage transitioned from his role as Interim Chief Financial Officer following the appointment of Elias Duncan as Acting CFO.

New Appointments:

Joseph R. Arron, M.D., Ph.D., Dr. Joseph R. Arron appointed to the role of Chief Scientific Officer.
Elias Duncan, Elias Duncan appointed as Acting Chief Financial Officer.
John Smolen, John Smolen appointed as Chief Commercial Officer.
William G. (Bill) Krenz, William (Bill) Krenz appointed as Chief Digital Officer.

What Technology (Tech Stack) Is Used by23andMe?

Discover the tools 23andMe uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

23andMe Email Formats and Examples

23andMe likely utilizes standard corporate email address formats for its employees. Common patterns include combinations of first name, last name, and initials followed by '@23andme.com'. These formats facilitate professional communication both internally and externally.

[first_initial][last]@23andme.com (e.g., jdoe@23andme.com) or [first].[last]@23andme.com (e.g., jane.doe@23andme.com)

Format

awojcicki@23andme.com (example for Anne Wojcicki, based on the f[last] pattern)

Example

70%

Success rate

What's the Latest News About 23andMe?

Reuters • April 18, 2024

23andMe CEO Anne Wojcicki Exploring Taking Company Private

Anne Wojcicki, CEO of 23andMe, announced she is considering making an offer to acquire all outstanding shares of the company to take it private. This move comes amid challenges in the biotech market and the company's stock performance....more

23andMe Investor Relations • March 5, 2024

23andMe Appoints Seasoned Digital Executive William (Bill) Krenz as Chief Digital Officer

23andMe announced the appointment of William G. (Bill) Krenz as its new Chief Digital Officer, tasked with leading the company's digital strategy and product innovation to enhance customer experience and drive growth....more

23andMe Investor Relations • February 7, 2024

23andMe Reports Q3 Fiscal 2024 Financial Results and Announces Workforce Reduction

23andMe announced its financial results for the third quarter of fiscal year 2024, highlighting progress in its therapeutics pipeline and consumer business. The company also reported a workforce reduction of approximately 9% (71 employees) as part of its efforts to streamline operations and focus on key strategic priorities....more

23andMe Investor Relations • January 16, 2024

23andMe Appoints John Smolen as Chief Commercial Officer

23andMe Holdings Co. announced John Smolen has joined as Chief Commercial Officer, responsible for leading the company's commercial functions including marketing, sales, and business development for its consumer business....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including 23andMe, are just a search away.